Medicine
Cefotaxime 10 g injection
Cefotaxime 10 g injection is a generic prescription medicine for intravenous use, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
NOTE: Cefotaxime for Injection, USP in the dry state should be stored at 20º…
Key facts
- Active ingredient (INN)
- Cefotaxime
- Brand
- Sold under the generic name
- Strength
- 10 g
- Dosage form
- Injection
- Route
- Intravenous
- Packs
- 1 injection
- Manufacturer
- Hikma Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- NOTE: Cefotaxime for Injection, USP in the dry state should be stored at 20º to 25°C (68º to 77°F). The dry material as well as solutions tend to darken depending on storage conditions and should be protected from elevated temperatures and excessive light.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- J01DD01 Cefotaxime
- HS code (indicative)
- 3004.20Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 20 November 2002
- Identifiers
- RxCUI 309065DailyMed set ID ef1a6dc6-bc3d-4f09-8f92-7ff328f56561NDC 0143-9935Application ANDA065071
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 injection in 1 package | 0143-9935-01 | Hikma Pharmaceuticals | 20 November 2002 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 11 March 1981 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Cefotaxime
Clinical summary
Cefotaxime is a cephalosporin antibacterial indicated for the treatment of patients with serious infections caused by susceptible strains of the designated microorganisms in the diseases listed below. MedsAcross supplies Cefotaxime for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about CefotaximeFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- CLAFORAN prescribing information (SteriMax) · U.S. National Library of Medicine, DailyMed
Need Cefotaxime 10 g injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.